Search | TVST | ARVO Journals

Showing 1 – 20 of 20

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina November 2024

Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema

PDF

Cheikh Diack; Robert L. Avery; Chui Ming Gemmy Cheung; Karl G. Csaky; Leonid Gibiansky; Felix Jaminion; Ekaterina Gibiansky; Denise Sickert; Ivo Stoilov; Valerie Cosson; Katrijn Bogman
TAGS: diabetic macular edema, exudative age-related macular degeneration, faricimab, hypertension, vascular endothelial growth factor a, pharmacodynamics
Trans. Vis. Sci. Tech.. 2024; 13(11):13. https://doi.org/10.1167/tvst.13.11.13

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Visual and Anatomic Outcomes in nAMD Patients with Subretinal Hemorrhage After Treatment with Faricimab in the TRUCKEE Study

Ohidul Mojumder; Aamir Abdul Aziz; Hannah Khan; Ashkan Michael Abbey; Robert L Avery; Himanshu K Banda; Mark Rami Barakat; Ramanath Bhandari; Emmanuel Chang; Sara Haug; Nikolas London; Veeral Sheth; Jeremy Wolfe; Michael Andrew Singer; Carl J Danzig; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5675.

Letters to the Editor October 2023

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME

PDF

Robert L. Avery; Karl G. Csaky; Peter Westenskow; Ivaylo Stoilov; Cheikh Diack
TAGS: aflibercept, angiopoietins
Trans. Vis. Sci. Tech.. 2023; 12(10):6. https://doi.org/10.1167/tvst.12.10.6

ARVO Annual Meeting Abstract June 2023

The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study

Aamir Abdul Aziz; Hannah Khan; Ashkan Michael Abbey; David RP Almeida; Robert L Avery; Himanshu K Banda; Mark Barakat; Ramanath Bhandari; Emmanuel Y Chang; Sara Haug; Nikolas J S London; Veeral Sheth; Jeremy Wolfe; Michael Andrew Singer; Carl J Danzig; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2190.

ARVO Annual Meeting Abstract June 2023

Visual and Anatomic Outcomes in nAMD Patients with Subretinal Hemorrhage After Treatment with Faricimab in the TRUCKEE Study

Hannah Khan; Aamir Abdul Aziz; Ashkan Michael Abbey; David RP Almeida; Robert L Avery; Himanshu K Banda; Mark Barakat; Ramanath Bhandari; Emmanuel Y Chang; Sara Haug; Nikolas J S London; Veeral Sheth; Jeremy Wolfe; Michael Andrew Singer; Carl J Danzig; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2187.

Special Issue October 2021

One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration

PDF

Amir H. Kashani; Jane S. Lebkowski; Firas M. Rahhal; Robert L. Avery; Hani Salehi-Had; Sanford Chen; Clement Chan; Neal Palejwala; April Ingram; Wei Dang; Chih-Min Lin; Debbie Mitra; Britney O. Pennington; Cassidy Hinman; Mohamed A. Faynus; Jeffrey K. Bailey; Sukriti Mohan; Narsing Rao; Lincoln V. Johnson; Dennis O. Clegg; David R. Hinton; Mark S. Humayun
TAGS: age-related macular degeneration, follow-up, implants, retinal pigment cell, surgical procedures, operative, postoperative care, therapeutic immunosuppression
Trans. Vis. Sci. Tech.. 2021; 10(10):13. https://doi.org/10.1167/tvst.10.10.13

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Identification of Photoreceptor Protein, Retinol Binding Protein 3 (RBP3), as a Protective Factor for Diabetic Retinopathy

Ward Fickweiler; Hisashi Yokomizo; Kyoungmin Park; Allen C Clermont; Yasutaka Maeda; Samantha M Paniagua; I-Hsien Wu; David Pober; Vanessa Bahnam; Robert L Avery; Timothy S Kern; Edward Feener; Lloyd P Aiello; Jennifer K Sun; George Liang King

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6427.

ARVO Annual Meeting Abstract July 2018

Treat and Extend Versus Bi-monthly dosing with Aflibercept for the Treatment of Diabetic Macular Edema, One Year Outcomes (EVADE Study)

Jack M Giust; Alessandro Castellarin; Nathan Steinle; Dante Joseph Pieramici; Robert F. See; Robert L Avery; Gabriel M Gordon; Dilsher Dhoot

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1957.

ARVO Annual Meeting Abstract July 2018

Does Anti-VEGF Treatment for AMD Lower the Risk of Neovascularization in the Fellow Eye? A Meta-analysis

Robert L Avery; Gabriel M Gordon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1474.

ARVO Annual Meeting Abstract June 2017

Cost Evaluation of Pneumatic Vitreolysis in Treatment for Vitreomacular Adhesion

Gabriel M Gordon; Robert L Avery

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1592.

ARVO Annual Meeting Abstract June 2017

Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated with Intravitreal Aflibercept Injection or Ranibizumab in the VIEW studies

Robert L Avery

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):420.

ARVO Annual Meeting Abstract September 2016

Comparison of Three Non-surgical Treatments for Vitreomacular Traction (VMT)

Nathan Steinle; Dilsher Dhoot; Dante Joseph Pieramici; Robert F See; Alessandro Castellarin; Steven Couvillion; Maan Nasir; Robert L Avery

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Eye Drop Adherence Following Retina Surgery

Daniel Glasser; Soratree Charoenthongtrakul; Hussein Wafapoor; Robert L Avery; Alexander M Eaton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4000.

ARVO Annual Meeting Abstract June 2015

Systemic Safety of Monthly Anti-VEGF Injections for Diabetic Macular Edema (DME)

Robert L Avery; Gabriel M Gordon

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1508.

ARVO Annual Meeting Abstract June 2015

Intravitreal Perfluoropropane Gas (C3F8) Versus Ocriplasmin for Vitreomacular Traction (VMT)

Nathan Steinle; Dilsher Dhoot; Carlos Quezada; Ma'an A Nasir; Dante Joseph Pieramici; Robert See; Steve Couvillion; Alessandro Castellarin; Robert L Avery

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3515.

ARVO Annual Meeting Abstract June 2015

In Vivo and In vitro Force Testing of a New Guarded Injection Device

Alexander M Eaton; Gabriel M Gordon; Dave Booth; Hussein Wafapoor; Robert L Avery; Dyson Hickingbotham

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):393.

Genetics April 2015

Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular Hypertension

PDF

Shinwu Jeong; Nitin Patel; Christopher K. Edlund; Jaana Hartiala; Dennis J. Hazelett; Tatsuo Itakura; Pei-Chang Wu; Robert L. Avery; Janet L. Davis; Harry W. Flynn; Geeta Lalwani; Carmen A. Puliafito; Hussein Wafapoor; Minako Hijikata; Naoto Keicho; Xiaoyi Gao; Pablo Argüeso; Hooman Allayee; Gerhard A. Coetzee; Mathew T. Pletcher; David V. Conti; Stephen G. Schwartz; Alexander M. Eaton; M. Elizabeth Fini
TAGS: cohort studies, genes, intraocular pressure, mucins, ocular hypertension, single nucleotide polymorphism, steroids, dna, proteins, genome-wide association study
Invest. Ophthalmol. Vis. Sci.. 2015; 56(4):2737-2748. https://doi.org/10.1167/iovs.14-14803

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Outer Band Reflectivity Changes on SD-OCT Following Intravitreal Ocriplasmin for Vitreomacular Traction (VMT) and macular holes (MH)

Nathan C Steinle; Carlos Quezada; Ma Nasir; Dante Joseph Pieramici; Alessandro Castellarin; Robert F See; Stephen Couvillion; Dilsher Dhoot; Melvin Rabena; Robert L Avery; California Retina Consultants

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):296.

ARVO Annual Meeting Abstract April 2014

Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients with DME

Robert L Avery; Alessandro Castellarin; Nathan Steinle; Dilsher Dhoot; Dante Joseph Pieramici; Robert F See; Stephen Couvillion; Ma Nasir; Kha Le; Jennifer Visich

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):586.

ARVO Annual Meeting Abstract April 2011

Ranibizumab for Macular Edema Secondary to Perfused Central Retinal Vein Occlusion- Three Year Study

Robert L. Avery; Dante Pieramici; Ma'an Nasir; Alessandro Castellarin; Robert See; Stephen Couvillion; Melvin Rabena; Jessica Basefsky

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3967.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema

Visual and Anatomic Outcomes in nAMD Patients with Subretinal Hemorrhage After Treatment with Faricimab in the TRUCKEE Study

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME

The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study

Visual and Anatomic Outcomes in nAMD Patients with Subretinal Hemorrhage After Treatment with Faricimab in the TRUCKEE Study

One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration

Identification of Photoreceptor Protein, Retinol Binding Protein 3 (RBP3), as a Protective Factor for Diabetic Retinopathy

Treat and Extend Versus Bi-monthly dosing with Aflibercept for the Treatment of Diabetic Macular Edema, One Year Outcomes (EVADE Study)

Does Anti-VEGF Treatment for AMD Lower the Risk of Neovascularization in the Fellow Eye? A Meta-analysis

Cost Evaluation of Pneumatic Vitreolysis in Treatment for Vitreomacular Adhesion

Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated with Intravitreal Aflibercept Injection or Ranibizumab in the VIEW studies

Comparison of Three Non-surgical Treatments for Vitreomacular Traction (VMT)

Eye Drop Adherence Following Retina Surgery

Systemic Safety of Monthly Anti-VEGF Injections for Diabetic Macular Edema (DME)

Intravitreal Perfluoropropane Gas (C3F8) Versus Ocriplasmin for Vitreomacular Traction (VMT)

In Vivo and In vitro Force Testing of a New Guarded Injection Device

Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular Hypertension

Outer Band Reflectivity Changes on SD-OCT Following Intravitreal Ocriplasmin for Vitreomacular Traction (VMT) and macular holes (MH)

Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients with DME

Ranibizumab for Macular Edema Secondary to Perfused Central Retinal Vein Occlusion- Three Year Study

To View More...

You must be signed into an individual account to use this feature.